BIOGEN INC. - COMMON STOCK

Biogen’s Litifilimab Demonstrates Rapid and Durable Efficacy in New 52-Week Phase 2 Data from Ongoing Phase 2/3 AMETHYST Study, Reinforcing Its Potential as a First-in-Class Therapy for Cutaneous Lupus Erythematosus

02 Oct 2026 11:20:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: BIOGEN INC. - COMMON STOCK

28 Sep 2026 11:36:05 By NetDania Notify

NetDania - New 12 months High: BIOGEN INC. - COMMON STOCK

23 Sep 2026 09:49:15 By NetDania Notify

NetDania - New 12 months High: BIOGEN INC. - COMMON STOCK

22 Sep 2026 11:30:51 By NetDania Notify

Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabilized Kidney Function in Adolescents with C3G or Primary IC-MPGN

17 Sep 2026 16:15:00 By Nasdaq GlobeNewswire

LEQEMBI® Pen (Subcutaneous Formulation of LEQEMBI®) Approved in Japan for the Treatment of Early Alzheimer’s Disease

16 Sep 2026 02:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: BIOGEN INC. - COMMON STOCK

03 Sep 2026 09:45:32 By NetDania Notify

NetDania - New 12 months High: BIOGEN INC. - COMMON STOCK

02 Sep 2026 11:45:21 By NetDania Notify

NetDania - New 12 months High: BIOGEN INC. - COMMON STOCK

25 Aug 2026 11:43:41 By NetDania Notify

NetDania - New 12 months High: BIOGEN INC. - COMMON STOCK

19 Aug 2026 10:09:13 By NetDania Notify

NetDania - New 12 months High: BIOGEN INC. - COMMON STOCK

29 Jun 2026 10:04:09 By NetDania Notify

NetDania - New 12 months High: BIOGEN INC. - COMMON STOCK

26 Jun 2026 09:50:20 By NetDania Notify

NetDania - New 12 months High: BIOGEN INC. - COMMON STOCK

25 Jun 2026 10:28:19 By NetDania Notify

NetDania - New 12 months High: BIOGEN INC. - COMMON STOCK

13 May 2026 10:00:36 By NetDania Notify

NetDania - New 12 months High: BIOGEN INC. - COMMON STOCK

06 Feb 2026 09:46:52 By NetDania Notify

Biogen Receives European Commission Approval for High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy

12 Jan 2026 11:05:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: BIOGEN INC. - COMMON STOCK

09 Jan 2026 09:47:21 By NetDania Notify

NetDania - New 12 months High: BIOGEN INC. - COMMON STOCK

08 Jan 2026 09:46:19 By NetDania Notify

NetDania - New 12 months High: BIOGEN INC. - COMMON STOCK

07 Jan 2026 10:14:30 By NetDania Notify

Biologics License Application for Subcutaneous Formulation of “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Accepted in China

05 Jan 2026 20:00:00 By Nasdaq GlobeNewswire